Search Page

1

Cite

Share

Influence of sampling schedules on [¹⁷⁷Lu]Lu-PSMA dosimetry.

Rinscheid A, Kletting P, Eiber M, Beer AJ, Glatting G. Rinscheid A, et al. Among authors: kletting p. EJNMMI Phys. 2020 Jun 17;7(1):41. doi: 10.1186/s40658-020-00311-0. EJNMMI Phys. 2020. PMID: 32556844 Free PMC article.

Cite

Share

2

Cite

Share

A population-based method to determine the time-integrated activity in molecular radiotherapy.

Hardiansyah D, Riana A, Kletting P, Zaid NRR, Eiber M, Pawiro SA, Beer AJ, Glatting G. Hardiansyah D, et al. Among authors: kletting p. EJNMMI Phys. 2021 Dec 14;8(1):82. doi: 10.1186/s40658-021-00427-x. EJNMMI Phys. 2021. PMID: 34905131 Free PMC article.

Cite

Share

3

Cite

Share

Mathematical Modeling of In Vivo Alpha Particle Generators and Chelator Stability.

Zaid NRR, Kletting P, Beer AJ, Rozgaja Stallons TA, Torgue JJ, Glatting G. Zaid NRR, et al. Among authors: kletting p. Cancer Biother Radiopharm. 2021 Jan 21. doi: 10.1089/cbr.2020.4112. Online ahead of print. Cancer Biother Radiopharm. 2021. PMID: 33481653

Cite

Share

4

Cite

Share

Modeling and Predicting Tumor Response in Radioligand Therapy.

Kletting P, Thieme A, Eberhardt N, Rinscheid A, D'Alessandria C, Allmann J, Wester HJ, Tauber R, Beer AJ, Glatting G, Eiber M. Kletting P, et al. J Nucl Med. 2019 Jan;60(1):65-70. doi: 10.2967/jnumed.118.210377. Epub 2018 May 10. J Nucl Med. 2019. PMID: 29748236 Free article.

Cite

Share

5

Cite

Share

Comparison of MRI-based and PET-based image pre-processing for quantification of ¹¹C-PBB3 uptake in human brain.

Yousefzadeh-Nowshahr E, Winter G, Bohn P, Kneer K, von Arnim CAF, Otto M, Solbach C, Anderl-Straub S, Polivka D, Fissler P, Prasad V, Kletting P, Riepe MW, Higuchi M, Ludolph A, Beer AJ, Glatting G. Yousefzadeh-Nowshahr E, et al. Among authors: kletting p. Z Med Phys. 2021 Feb;31(1):37-47. doi: 10.1016/j.zemedi.2020.12.002. Epub 2021 Jan 14. Z Med Phys. 2021. PMID: 33454153

Cite

Share

6

Cite

Share

A Physiologically Based Pharmacokinetic Model for In Vivo Alpha Particle Generators Targeting Neuroendocrine Tumors in Mice.

Zaid NRR, Kletting P, Winter G, Prasad V, Beer AJ, Glatting G. Zaid NRR, et al. Among authors: kletting p. Pharmaceutics. 2021 Dec 10;13(12):2132. doi: 10.3390/pharmaceutics13122132. Pharmaceutics. 2021. PMID: 34959413 Free PMC article.

Cite

Share

7

Cite

Share

An in silico study on the effect of the radionuclide half-life on PET/CT imaging with PSMA-targeting radioligands.

Begum NJ, Glatting G, Eiber M, Beer AJ, Kletting P. Begum NJ, et al. Among authors: kletting p. Nuklearmedizin. 2021 Feb;60(1):33-37. doi: 10.1055/a-1253-1535. Epub 2020 Oct 16. Nuklearmedizin. 2021. PMID: 33137837 English.

Cite

Share

8

Cite

Share

Important pharmacokinetic parameters for individualization of ¹⁷⁷ Lu-PSMA therapy: A global sensitivity analysis for a physiologically-based pharmacokinetic model.

Hardiansyah D, Kletting P, Begum NJ, Eiber M, Beer AJ, Pawiro SA, Glatting G. Hardiansyah D, et al. Among authors: kletting p. Med Phys. 2021 Feb;48(2):556-568. doi: 10.1002/mp.14622. Epub 2020 Dec 15. Med Phys. 2021. PMID: 33244792

Cite

Share

9

Cite

Share

Effect of Tumor Perfusion and Receptor Density on Tumor Control Probability in ¹⁷⁷Lu-DOTATATE Therapy: An In Silico Analysis for Standard and Optimized Treatment.

Jiménez-Franco LD, Glatting G, Prasad V, Weber WA, Beer AJ, Kletting P. Jiménez-Franco LD, et al. Among authors: kletting p. J Nucl Med. 2021 Jan;62(1):92-98. doi: 10.2967/jnumed.120.245068. Epub 2020 Jul 9. J Nucl Med. 2021. PMID: 32646878 Free article.

Cite

Share

10

Cite

Share

Modelling the internalisation process of prostate cancer cells for PSMA-specific ligands.

Winter G, Vogt A, Jiménez-Franco LD, Rinscheid A, Yousefzadeh-Nowshahr E, Solbach C, Beer AJ, Glatting G, Kletting P. Winter G, et al. Among authors: kletting p. Nucl Med Biol. 2019 May-Jun;72-73:20-25. doi: 10.1016/j.nucmedbio.2019.05.003. Epub 2019 May 29. Nucl Med Biol. 2019. PMID: 31260881

Cite

Share